Navigation Links
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
Date:1/12/2009

SAN DIEGO, Jan. 12 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today it has received clearance from the U.S. Food and Drug Administration to market the BD GeneOhm(TM) Cdiff molecular assay for the rapid detection of the Toxin B gene found in toxigenic Clostridium difficile, the bacterial pathogen responsible for Clostridium difficile infection (CDI). It is the first CDI molecular diagnostic that offers sensitivity, simplicity and speed in one test procedure.

"The BD GeneOhm Cdiff assay provides a simple and rapid stool test with excellent sensitivity and specificity that allows same-day identification of toxigenic Clostridium difficile," said Thomas Davis, M.D., Ph.D., Professor, Pathology and Laboratory Medicine at the Indiana University School of Medicine, and Pathologist with Wishard Health Services and Clarian Health laboratories. "This test should improve patient care because it gives labs the option of a single assay that will markedly reduce or even eliminate the need for multiple screening and confirmatory tests. This would speed up reporting and help avoid unnecessary antibiotic use."

In the United States, an estimated 500,000 people are infected annually, and more than 28,000 die from CDI. A recent national survey conducted by the Association for Professionals in Infection Control and Epidemiology suggests that 13 out of every 1,000 hospitalized patients are suffering from CDI, and more than 7,000 patients in U.S. hospitals have CDI on any given day. The average length of stay for a CDI patient is nearly three times longer than the typical patient, and CDI is estimated to lead to $1 billion in excess healthcare costs annually in the United States. CDI rates continue to increase, driven by a new epidemic strain known as BI/
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue
2. Allen Technologies, Inc. Announces Vigo Interactive Communication and Education System Agreement with Saint John's Health Center, Santa Monica, California
3. Rubicon Genomics Announces a Licensing Agreement With Abbott to Develop and Commercialize DNA Methylation Cancer Tests
4. Oleen Pinnacle Announces Acquisition of Partners in Health Systems
5. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
6. Miami Beach Real Estate Attorney Announces Specialized Legal and Realty Services for Clients Buying Bank-Owned Luxury Miami Beach Condos
7. Genomma Lab Announces Initiation of Stock Repurchase Fund
8. Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference
9. VA Announces $22 Million for Rural Veterans
10. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
11. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Pennsylvania (PRWEB) June 18, 2013 Sun Buick ... and Family Health Services 20th Annual Golf Tournament on Thursday, ... , The hole-in-one prize is a 2013 Buick Verano and ... who gets a hole-in-one on Irem’s 7th hole. , The ... tournament format is a four person captain and crew team ...
(Date:6/18/2013)... 2013 Internationally acclaimed plastic surgeon, ... thebestbreast.com, showcasing his unique approach to breast augmentation. ... his surgical method and highlights the results of ... website, Dr. Tebbetts compares his breast augmentation method ... Tebbetts’ method does not necessitate the use drains, ...
(Date:6/18/2013)... Center clinical researchers have launched an innovative clinical ... the ability of a patient,s own stem cells ... arterial disease (PAD). , Led by Vik ... Hospitals Case Medical Center,s Harrington Heart & Vascular ... Reserve University School of Medicine, the clinical trial ...
(Date:6/18/2013)... HOUSTON Researchers have discovered and mapped the signaling ... that, if broken, could cut off cancer cell growth ... scientists at The University of Texas MD Anderson Cancer ... (EGFR), a well-known cancer drug target, and MCM7, a ... in the June issue of Cancer Cell . ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
Breaking Medicine News(10 mins):Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Skin Care – Getting Your Body Beach Ready 2
... Chains; 6 Receive an ,F, NEW YORK, Aug. ... your children fat? A year-long study of children,s meals ... sit-down,chain restaurants, according to the authors of the new ... and Matt Goulding calculated,calories, fat (trans- and saturated), and ...
... services for cardiovascular ... ... leader in disease prevention, announced today that the City of Tempe,Arizona ... have asthma or diabetes and are covered under the City,s PPO,Medical ...
... Current strategies can,t beat this growing challenge, researchers say ... of treating tuberculosis are failing in countries with high ... say researchers who analyzed World Health Organization data from ... countries with high rates of MDR-TB, patients are nearly ...
... that builds on healthcare reform proposal, WASHINGTON, ... today by Senators Max Baucus (D-MT) and Kent ... officer of the Blue,Cross and Blue Shield Association ... Senators Baucus and Conrad for introducing legislation that,would ...
... higher risk; doctors urged to expand education efforts , , ... at higher risk for HIV/AIDS, and doctors need to ... tested for HIV. , That,s the new recommendation released ... (ACOG). , "Rates of infection among African Americans ...
... available in <A HREF="http://www.eurekalert.org/pub_releases_ml/2008-08/aaft-t080108.php,">German . , , If someone ... change, but they don,t immediately pull off one of ... leg. With some molecules, however, the situation is quite ... seven atoms. In a charged state, the atoms arrange ...
Cached Medicine News:Health News:America's Worst Restaurants for Kids Revealed 2Health News:America's Worst Restaurants for Kids Revealed 3Health News:America's Worst Restaurants for Kids Revealed 4Health News:America's Worst Restaurants for Kids Revealed 5Health News:City of Tempe, Arizona Extends Contract with U.S. Preventive Medicine for Employee Health Management Program 2Health News:City of Tempe, Arizona Extends Contract with U.S. Preventive Medicine for Employee Health Management Program 3Health News:Drug Resistance Is Slowing Global Fight Against TB 2Health News:BCBSA: Time Is Right for Comparative Effectiveness Research Institute 2Health News:Ob/Gyn Group Urges Routine HIV Tests for All Women 2Health News:Nano sculptures in gold 2Health News:Nano sculptures in gold 3Health News:Nano sculptures in gold 4
(Date:6/18/2013)... , Safinamide significantly improves ... as add-on to levodopa Safinamide is ... in fluctuating PD patients as add-on to levodopa ... ("Newron"), a research and development company focused on ... Zambon S.p.A., a pharmaceutical company strongly committed to ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... VPII Escrow Corp., a newly formed wholly owned Canadian ... approximately $3.2 billion aggregate principal amount of senior unsecured ... 2021 and in 2023, with final tranching determined at ... net proceeds from the offering, together with proceeds from ...
(Date:6/18/2013)... 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share.  In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
...  GenVec, Inc. (Nasdaq: GNVC ) will report financial ... 2011 on Thursday, March 15, 2012, before the U.S. financial ... and conference call at 10:00 a.m. EDT to discuss the ... outlook. To listen to the live conference ...
... release of System 7 – the next generation of heavy ... such as hip and knee replacements. System 7 offers the ... and highest performing power tool system ever from Stryker. ... heavy duty power tools in 1982, and has built a ...
Cached Medicine Technology:GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012 2Stryker Launches Next Generation Heavy Duty Surgical Power Tools 2
FM Style Neonatal Flowmeters (Brass Body)...
... Proficiency Institute offers innovative proficiency testing solutions ... As a result, API is one of ... world with over 12,000 laboratories enrolled. Here ... using API:, Paperless Proficiency Testing, ...
... System is an automated multiplexing platform that ... detection, pathogen sequence detection and pharmacogenetics applications. ... applied to an open and flexible electronic ... reused until all tests sites have been ...
Assess serum Gc-globulin levels in patients with multiple trauma, fulminant liver failure, acetaminophen overdose, and sepsis....
Medicine Products: